Advertisement
Singapore markets close in 2 hours 54 minutes

  • Straits Times Index

    3,406.37
    +38.47 (+1.14%)
     

  • Nikkei

    40,621.39
    +546.70 (+1.36%)
     

  • Hang Seng

    17,956.35
    +187.21 (+1.05%)
     

  • FTSE 100

    8,121.20
    -45.56 (-0.56%)
     

  • Bitcoin USD

    60,999.89
    -1,975.33 (-3.14%)
     

  • CMC Crypto 200

    1,312.25
    -22.67 (-1.70%)
     

  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     

  • Dow

    39,331.85
    +162.33 (+0.41%)
     

  • Nasdaq

    18,028.76
    +149.46 (+0.84%)
     

  • Gold

    2,341.40
    +8.00 (+0.34%)
     

  • Crude Oil

    83.14
    +0.33 (+0.40%)
     

  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     

  • FTSE Bursa Malaysia

    1,607.10
    +9.14 (+0.57%)
     

  • Jakarta Composite Index

    7,144.28
    +19.13 (+0.27%)
     

  • PSE Index

    6,415.77
    +56.81 (+0.89%)
     

Ionis Pharmaceuticals: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Tuesday reported a loss of $143 million in its first quarter.

The Carlsbad, California-based company said it had a loss of 98 cents per share.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.

The drug discovery and development company posted revenue of $119 million in the period, falling short of Street forecasts. Seven analysts surveyed by Zacks expected $131.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS